Cargando…
p21 in Cancer Research
p21 functions as a cell cycle inhibitor and anti-proliferative effector in normal cells, and is dysregulated in some cancers. Earlier observations on p21 knockout models emphasized the role of this protein in cell cycle arrest under the p53 transcription factor activity. Although tumor-suppressor fu...
Autores principales: | Shamloo, Bahar, Usluer, Sinem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721478/ https://www.ncbi.nlm.nih.gov/pubmed/31416295 http://dx.doi.org/10.3390/cancers11081178 |
Ejemplares similares
-
p53 Transactivation Domain Mediates Binding and Phase Separation with Poly-PR/GR
por: Usluer, Sinem, et al.
Publicado: (2021) -
p21-activated kinase signaling in breast cancer
por: Gururaj, Anupama E, et al.
Publicado: (2005) -
Function of p21 and its therapeutic effects in esophageal cancer
por: Wang, Lei, et al.
Publicado: (2021) -
p21-Activated Kinase: Role in Gastrointestinal Cancer and Beyond
por: Li, Xiaodong, et al.
Publicado: (2022) -
ATP regulates RNA‐driven cold inducible RNA binding protein phase separation
por: Zhou, Qishun, et al.
Publicado: (2021)